CDC and FDA Support Additional Bivalent COVID-19 Booster for Adults 65 and Older, Immunocompromised
The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have released updated COVID-19 vaccine recommendations. Highlights include: People 65 years of age and older who have received a single dose of an updated (bivalent) vaccine may receive one additional bivalent dose at least four months after their initial bivalent dose. [...]